Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. on July 23, 2024, covering events occurring on July 23 and July 24, 2024. The company is incorporated in Delaware and trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a capital structure event.
Material Changes
- Preferred Stock Conversion: On July 23, 2024, the company converted 400 shares of its outstanding Series A Convertible Preferred Stock into 25,000 shares of common stock.
- Issuance Date: The 25,000 shares of common stock were issued on July 24, 2024.
- Capital Structure Impact: Following this conversion, there are no shares of Series A Preferred Stock remaining outstanding.
- Regulatory Basis: The transaction was executed under the exemption in Section 3(a)(9) of the Securities Act of 1933, as no commission was paid for soliciting the exchange.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The shares issued have been registered for resale on an effective Form S-1 registration statement.
Investor Verification Checklist
- Verify the total number of common shares outstanding post-conversion in the latest 10-Q or 10-K.
- Confirm the effective status of the Form S-1 registration statement referenced for resale of the new shares.
- Review the terms of the Series A Preferred Stock to understand the conversion ratio and any prior dividend obligations.